Connection

Co-Authors

This is a "connection" page, showing publications co-authored by HAGOP M KANTARJIAN and ISSAM I RAAD.
Connection Strength

0.844
  1. Impact of Catheter Management on Clinical Outcome in Adult Cancer Patients With Gram-Negative Bacteremia. Open Forum Infect Dis. 2019 Oct; 6(10):ofz357.
    View in: PubMed
    Score: 0.174
  2. Neuraminidase inhibitors improve outcome of patients with leukemia and influenza: an observational study. Clin Infect Dis. 2007 Apr 01; 44(7):964-7.
    View in: PubMed
    Score: 0.072
  3. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis. 2005 Apr 15; 191(8):1350-60.
    View in: PubMed
    Score: 0.063
  4. Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies. Cancer. 2004 Oct 01; 101(7):1594-600.
    View in: PubMed
    Score: 0.061
  5. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial. J Clin Oncol. 2004 Aug 01; 22(15):3163-71.
    View in: PubMed
    Score: 0.061
  6. Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infections. J Antimicrob Chemother. 2004 Apr; 53(4):646-9.
    View in: PubMed
    Score: 0.059
  7. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime. Cancer. 2003 Sep 01; 98(5):1039-47.
    View in: PubMed
    Score: 0.057
  8. Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies. Cancer. 2003 Jul 15; 98(2):292-9.
    View in: PubMed
    Score: 0.056
  9. Development of Varicella-Zoster virus infection in patients with chronic myelogenous leukemia treated with imatinib mesylate. Clin Cancer Res. 2003 Mar; 9(3):976-80.
    View in: PubMed
    Score: 0.055
  10. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome. Cancer. 2003 Jan 15; 97(2):450-6.
    View in: PubMed
    Score: 0.055
  11. Masking of neutropenic patients on transport from hospital rooms is associated with a decrease in nosocomial aspergillosis during construction. Infect Control Hosp Epidemiol. 2002 Jan; 23(1):41-3.
    View in: PubMed
    Score: 0.051
  12. Characteristics and outcome of respiratory syncytial virus infection in patients with leukemia. Haematologica. 2007 Sep; 92(9):1216-23.
    View in: PubMed
    Score: 0.019
  13. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions. Cancer. 2006 Jun 15; 106(12):2664-71.
    View in: PubMed
    Score: 0.017
  14. Intravenous itraconazole for prophylaxis of systemic fungal infections in patients with acute myelogenous leukemia and high-risk myelodysplastic syndrome undergoing induction chemotherapy. Cancer. 2004 Feb 01; 100(3):568-73.
    View in: PubMed
    Score: 0.015
  15. Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy. Cancer. 2004 Feb 01; 100(3):581-9.
    View in: PubMed
    Score: 0.015
  16. Infections in patients with aplastic anemia: experience at a tertiary care cancer center. Cancer. 2003 Jul 01; 98(1):86-93.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.